CN104203224A - 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物 - Google Patents

含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物 Download PDF

Info

Publication number
CN104203224A
CN104203224A CN201380014630.8A CN201380014630A CN104203224A CN 104203224 A CN104203224 A CN 104203224A CN 201380014630 A CN201380014630 A CN 201380014630A CN 104203224 A CN104203224 A CN 104203224A
Authority
CN
China
Prior art keywords
aqueous composition
amino
bromobenzoyl
polyoxyethylene sorbitan
sorbitan fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380014630.8A
Other languages
English (en)
Chinese (zh)
Inventor
森本隆司
浅田博之
高桥恭平
冈本智之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of CN104203224A publication Critical patent/CN104203224A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN201380014630.8A 2012-03-28 2013-03-28 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物 Pending CN104203224A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-073181 2012-03-28
JP2012073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (ja) 2012-03-28 2013-03-28 ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
CN104203224A true CN104203224A (zh) 2014-12-10

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380014630.8A Pending CN104203224A (zh) 2012-03-28 2013-03-28 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物

Country Status (9)

Country Link
JP (1) JP5922609B2 (enExample)
KR (1) KR20140139501A (enExample)
CN (1) CN104203224A (enExample)
IN (1) IN2014DN07767A (enExample)
MY (1) MY170840A (enExample)
PH (1) PH12014502171A1 (enExample)
SG (1) SG11201405837YA (enExample)
TW (1) TWI604858B (enExample)
WO (1) WO2013147000A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111712238A (zh) * 2017-12-14 2020-09-25 参天制药株式会社 含有2-氨基-3-（4-溴苯甲酰基）苯乙酸或其盐的滴眼剂

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017002042A (ja) * 2015-06-10 2017-01-05 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101965183A (zh) * 2008-02-21 2011-02-02 伊斯塔药品公司 作为佐剂的眼用nsaid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
ES2381672T3 (es) * 2003-11-14 2012-05-30 Senju Pharmaceutical Co., Ltd. Preparación en solución acuosa que comprende un antibiótico aminoglicósido y bromfenaco
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
KR102075173B1 (ko) * 2011-01-18 2020-02-07 센주 세이야꾸 가부시키가이샤 보존 효력을 갖는 브롬페낙 수성 액제 조성물
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101965183A (zh) * 2008-02-21 2011-02-02 伊斯塔药品公司 作为佐剂的眼用nsaid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111712238A (zh) * 2017-12-14 2020-09-25 参天制药株式会社 含有2-氨基-3-（4-溴苯甲酰基）苯乙酸或其盐的滴眼剂

Also Published As

Publication number Publication date
JP5922609B2 (ja) 2016-05-24
JP2013227300A (ja) 2013-11-07
PH12014502171A1 (en) 2014-12-10
MY170840A (en) 2019-09-10
TW201343197A (zh) 2013-11-01
SG11201405837YA (en) 2014-11-27
KR20140139501A (ko) 2014-12-05
IN2014DN07767A (enExample) 2015-05-15
TWI604858B (zh) 2017-11-11
WO2013147000A1 (ja) 2013-10-03

Similar Documents

Publication Publication Date Title
US11439652B2 (en) Ophthalmic aqueous composition
KR102607126B1 (ko) 안과용 조성물
RU2019119405A (ru) Лиофилизированные фармацевтические композиции далбаванцина
CN102784382B (zh) 一种阿加曲班药物组合物及其制备方法和应用
CN104203224A (zh) 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
WO2018221487A1 (ja) エリブリンまたはその薬剤学的に許容される塩を含む注射剤
CN114630669B (zh) 稳定的医药组合物
CN105451731A (zh) 含有经稳定化的2－氨基－3－(4－溴苯甲酰基)苯乙酸的水性组合物
WO2019123406A1 (en) Novel formulations of vasopressin
HK1220393B (zh) 含有经稳定化的2-氨基-3-(4-溴苯甲醯基)苯乙酸的水性组合物
JPWO2005053708A1 (ja) ロテプレドノールエタボネート水性懸濁液剤
JP4832015B2 (ja) オキシグルタチオン含有水溶液
JP7090845B2 (ja) パロノセトロン含有液体組成物
HK40074840A (en) Stable pharmaceutical composition
HK40074840B (zh) 稳定的医药组合物
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
HK1235711A1 (en) Ophthalmic aqueous composition
HK1235711B (en) Ophthalmic aqueous composition
WO2017091165A1 (en) Liquid formulation of levodropropizine and method for preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141210

RJ01 Rejection of invention patent application after publication